MDT

97.56

-1.22%↓

A

148.57

+2%↑

VEEV

239.64

-0.58%↓

HQY

94.29

-4.24%↓

PHR.US

17.17

+1.72%↑

MDT

97.56

-1.22%↓

A

148.57

+2%↑

VEEV

239.64

-0.58%↓

HQY

94.29

-4.24%↓

PHR.US

17.17

+1.72%↑

MDT

97.56

-1.22%↓

A

148.57

+2%↑

VEEV

239.64

-0.58%↓

HQY

94.29

-4.24%↓

PHR.US

17.17

+1.72%↑

MDT

97.56

-1.22%↓

A

148.57

+2%↑

VEEV

239.64

-0.58%↓

HQY

94.29

-4.24%↓

PHR.US

17.17

+1.72%↑

MDT

97.56

-1.22%↓

A

148.57

+2%↑

VEEV

239.64

-0.58%↓

HQY

94.29

-4.24%↓

PHR.US

17.17

+1.72%↑

Search

Odonate Therapeutics Inc

Fermé

0

Résumé

Variation du prix de l'action

24h

Actuel

Min

Max

Chiffres clés

By Trading Economics

Odonate Therapeutics Inc Graphique

Les performances passées ne sont pas un indicateur fiable des résultats futurs.

Actualités Associées

10 janv. 2026, 00:16 UTC

Acquisitions, Fusions, Rachats

Edwards Lifesciences Drops Merger With JenaValve

11 janv. 2026, 23:46 UTC

Market Talk

Gold Rises Amid Geopolitical Risks -- Market Talk

11 janv. 2026, 23:35 UTC

Market Talk

Oil Rises Amid Middle East Tensions -- Market Talk

11 janv. 2026, 23:25 UTC

Résultats

Stock Futures Drift Lower With Bank Earnings, CPI on Tap -- Barrons.com

11 janv. 2026, 22:05 UTC

Market Talk

Iron Ore Outlook Weighed by Soft China Steel Markets, Rising Supply -- Market Talk

10 janv. 2026, 12:00 UTC

Acquisitions, Fusions, Rachats

Copper Is the Prize in Mining Megadeals -- WSJ

10 janv. 2026, 09:20 UTC

Market Talk

Tech, Media & Telecom Roundup: Market Talk

10 janv. 2026, 09:20 UTC

Market Talk
Acquisitions, Fusions, Rachats

Basic Materials Roundup: Market Talk

10 janv. 2026, 09:20 UTC

Market Talk

Financial Services Roundup: Market Talk

9 janv. 2026, 22:18 UTC

Market Talk

Changes Needed for Exxon Mobil to Return to Venezuela -- Market Talk

9 janv. 2026, 21:50 UTC

Market Talk

Energy & Utilities Roundup: Market Talk

9 janv. 2026, 21:50 UTC

Market Talk
Acquisitions, Fusions, Rachats

Basic Materials Roundup: Market Talk

9 janv. 2026, 21:50 UTC

Market Talk

Financial Services Roundup: Market Talk

9 janv. 2026, 21:50 UTC

Market Talk

Tech, Media & Telecom Roundup: Market Talk

9 janv. 2026, 21:43 UTC

Résultats
Acquisitions, Fusions, Rachats

These Stocks Moved the Most Today: Oklo, Vistra, Opendoor, Intel, GM, Revolution Medicines, Tilray, and More -- Barrons.com

9 janv. 2026, 20:39 UTC

Market Talk

GE Vernova Seen With Rising Concern of Overcapacity -- Market Talk

9 janv. 2026, 20:38 UTC

Market Talk

U.S. Natural Gas Falls on Loose Supply Outlook -- Market Talk

9 janv. 2026, 20:36 UTC

Acquisitions, Fusions, Rachats

Cathie Wood's ARK Invest Takes a New Stake in Broadcom -- and Sold Another Hot Stock -- Barrons.com

9 janv. 2026, 20:30 UTC

Market Talk

Oil Makes Weekly Gains in Geopolitically Driven Trade -- Market Talk

9 janv. 2026, 20:15 UTC

Market Talk

Chevron Seen With Modest Opportunity to Boost Venezuela Oil Production -- Market Talk

9 janv. 2026, 20:07 UTC

Market Talk

Global Equities Roundup: Market Talk

9 janv. 2026, 20:07 UTC

Market Talk

Goldman Sachs' Pivot from Consumer Lending Seen as Positive -- Market Talk

9 janv. 2026, 19:58 UTC

Acquisitions, Fusions, Rachats

Merck in Talks to Buy Revolution Medicines for Around $30 Billion -- WSJ

9 janv. 2026, 19:42 UTC

Market Talk

Adobe Seen With Weak Competitive Position Compared to Rivals -- Market Talk

9 janv. 2026, 19:38 UTC

Acquisitions, Fusions, Rachats

Wolters Kluwer Acquires StandardFusion >WTKWY

9 janv. 2026, 19:31 UTC

Résultats

Qualcomm Stock Falls After Downgrade. The Apple Supplier Has an iPhone Problem. -- Barrons.com

9 janv. 2026, 19:28 UTC

Résultats

Apple Stock Set to Break Brutal Losing Streak. Why It Remains Evercore's 'Top Pick.' -- Barrons.com

9 janv. 2026, 18:30 UTC

Market Talk

U.S. Oil Rig Count Falls by 3 to 409 -- Market Talk

9 janv. 2026, 18:23 UTC

Market Talk

Reports of Canada Oil Sector's Demise Are Premature -- Market Talk

9 janv. 2026, 17:20 UTC

Market Talk
Acquisitions, Fusions, Rachats

Basic Materials Roundup: Market Talk

Comparaison

Variation de prix

Odonate Therapeutics Inc prévision

Éléments financiers

Frais Généraux et Administratifs

Dépenses d'exploitation

Résultat avant impôt

Ventes

Coût des ventes

Marge brute des ventes

EBITDA

Bénéfice d'exploitation

$

À Propos Odonate Therapeutics Inc

Odonate, Inc., a pharmaceutical company, develops therapeutics for the treatment of cancer. It is developing tesetaxel, an orally administered chemotherapy agent, which is in Phase III clinical study for patients with metastatic breast cancer. The company was formerly known as Odonate Therapeutics, Inc. and changed its name to Odonate, Inc. in March 2023. The company was founded in 2013 and is based in New York, New York.
help-icon Live chat